University of Southampton / en Using our innovative antibody know-how to enhance the power of nature /innovation/magazine/detail/article/using-our-innovative-antibody-know-how-to-enhance-the-power-of-nature <span>Using our innovative antibody know-how to enhance the power of nature</span> <div class="field field--name-field-newsroom-author-title field--type-string field--label-above field__items"> David Humphreys, Discovery Science </div> <span><span lang about="/user/1" typeof="schema:Person" property="schema:name" datatype>eCMSadmin</span></span> <span><time datetime="2021-09-13T02:00:00+02:00" title="Monday 13 September 2021 - 02:00">Mon 13/09/2021 - 02:00</time> </span> <div class="field field--name-field-newsroom-author-image field--type-entity-reference field--label-above field__items"> <article class="media media--type-image media--view-mode-default"> <div class="field field--name-image field--type-image field--label-hidden field__items"> <img loading="lazy" src="/sites/default/files/styles/ucb_header_image/public/author_images/David_Humphreys.jpg.webp?itok=1mWA-sh5" width="50" height="50" alt="David Humphreys, Discovery Science" typeof="foaf:Image"> </div> </article> </div> <div class="field field--name-field-newsroom-content field--type-text-long field--label-above field__items"> <div>&nbsp;<br>Together with researchers at the University of Southampton, ½ðºÌÓéÀÖ³Ç used its antibody expertise and innovative protein engineering to harness part of the human immune system known as the complement cascade to enhance the natural ability of therapeutic antibodies to attack blood cancer cells.<br><br>Recently published in Communications Biology (part of the Nature portfolio) the new technology builds on previous research from ½ðºÌÓéÀÖ³Ç and harnesses a natural feature found at the end of Immunoglobulin M (IgM), an antibody with naturally high levels of complement activation, called a ‘tailpiece’. The tailpiece critically contributes to the formation of IgM hexamers. Antibody hexamerisation is a critical feature for activation of the complement system to attack cancer cells. By making a subtle modification to the tailpiece it enabled the Immunoglobulin G (IgG) - which is preferred for the treatment of human diseases - to retain its desirable properties but also take on the hexameric properties of IgM when bound to the target cell. This approach combines the best features of both antibody types into a single molecule and may open the way for a potential new class of treatments.<br><br>The new method was shown to be effective in several different antibodies. This makes it potentially attractive as a ‘plug-and-play’ modification tool to improve the performance of existing antibodies or create ‘bio-betters’ from existing therapeutics. To read more, the full (open access) paper can be accessed <a href="https://www.nature.com/articles/s42003-021-02513-3" class="disclaimer-1" target="_blank">here</a>.<br><br>The research was the product of a UKRI government-½ðºÌÓéÀÖ³Ç co-funded PhD studentship collaboration (BBSRC grant BB/N5039927/1) between blood cancer experts at the University of Southampton and antibody engineering experts at ½ðºÌÓéÀÖ³Ç. <br><br></div> </div> <div class="field field--name-field-newsroom-category field--type-entity-reference field--label-above field__items"> <a href="/taxonomy/term/1910" hreflang="en">innovation</a> </div> <div class="field field--name-field-newsroom-tags field--type-entity-reference field--label-above field__items"> <a href="/taxonomy/term/1277" hreflang="en">R&amp;D</a> <a href="/taxonomy/term/1377" hreflang="en">R&amp;D</a> <a href="/taxonomy/term/5324" hreflang="en"> University of Southampton</a> <a href="/taxonomy/term/5325" hreflang="en"> Antibody hexamerisation </a> </div> <div> <div class="comments-wrapper"> <div class="comment-area"> <h2 class="red">Leave a Comment</h2> <drupal-render-placeholder callback="comment.lazy_builders:renderForm" arguments="0=node&amp;1=12148&amp;2=field_newsroom_askexpert&amp;3=ask_expert" token="43HQYJPvXdt7S8U-3OfgxjOSaoh1ad-zEYLtTwrqLXs"></drupal-render-placeholder> <span class="toggle-form js-toggle-form"></span> </div> </div> </div> <span class="a2a_kit a2a_kit_size_16 addtoany_list" data-a2a-url="/innovation/magazine/detail/article/using-our-innovative-antibody-know-how-to-enhance-the-power-of-nature" data-a2a-title="Using our innovative antibody know-how to enhance the power of nature"><a class="a2a_dd addtoany_share" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.ucb.com%2Finnovation%2Fmagazine%2Fdetail%2Farticle%2Fusing-our-innovative-antibody-know-how-to-enhance-the-power-of-nature&amp;title=Using%20our%20innovative%20antibody%20know-how%20to%20enhance%20the%20power%20of%20nature"></a><a class="a2a_button a2a_button_facebook"><img src="/themes/custom/ucb_premier/images/a2a/facebook-icon.svg" width="16" height="16" border="0" alt="linkedin"></a><a class="a2a_button a2a_button_linkedin"><img src="/themes/custom/ucb_premier/images/a2a/linkedin-icon.svg" width="16" height="16" border="0" alt="linkedin"></a><a class="a2a_button a2a_button_twitter"><img src="/themes/custom/ucb_premier/images/a2a/twitter-icon.svg" width="16" height="16" border="0" alt="twitter"></a></span> <div class="field field--name-field-like field--type-likes-dislikes field--label-above field__items"> <div class="like_dislike"> <div class="like"> <a rel="nofollow" class="use-ajax" href="/like-dislike/like/eyJlbnRpdHlfdHlwZSI6Im5vZGUiLCJlbnRpdHlfaWQiOiIxMjE0OCIsImZpZWxkX25hbWUiOiJmaWVsZF9saWtlIiwibGlrZXMiOiI4NDUiLCJkaXNsaWtlcyI6bnVsbH0%3D"></a> <span class="like-12148"> 845 Likes </span> </div> </div> <div id="like_dislike_status"></div> </div> Mon, 13 Sep 2021 00:00:00 +0000 eCMSadmin 12148 at